Business
Disc Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference
WATERTOWN, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that John Quisel, J.D., Ph.D., President and Chief Executive Officer, will give a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th at 3:00 pm PT / 6:00 pm ET. A
About this update from Disc Medicine, Inc.
[{"type":"image","alt":"Disc Medicine Inc","displaySize":"","headline":null,"caption":"Disc Medicine Inc","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":46,"url":"https://media.zenfs.com/en/globenewswire.com/252ca54b96660d2e5211649d65d2516d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/DUkrd_0R95Z67I1Tbxqz4g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTY0O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/252ca54b96660d2e5211649d65d2516d","width":300,"height":46}},"lazy":false},{"type":"text","content":"WATERTOWN, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that John Quisel, J.D., Ph.D., President and Chief Executive Officer, will give a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th at 3:00 pm PT / 6:00 pm ET.","length":497,"tagName":"p"},{"type":"text","content":"A live webcast of the presentation will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available after the event.","length":201,"tagName":"p"},{"type":"text","content":"About Disc Medicine","length":19,"tagName":"p"},{"type":"text","content":"Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.","length":542,"tagName":"p"},{"type":"text","content":"Media Contact","length":13,"tagName":"p"},{"type":"text","content":"Peg RusconiDeerfield [email protected]","length":58,"tagName":"p"},{"type":"text","content":"Investor Relations Contact","length":26,"tagName":"p"},{"type":"text","content":"Christina TartagliaPrecision AQ [email protected]","length":69,"tagName":"p"},{"type":...